The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IRX4204 in combination with erlotinib to target distinct pathways in lung cancer cells.
 
Xi Liu
No Relationships to Disclose
 
Jason Roszik
No Relationships to Disclose
 
Masanori Karakami
No Relationships to Disclose
 
Martin Sanders
Employment - Io Therapeutics; Juno Therapeutics (I); Roche (I)
Leadership - Io Therapeutics; Juno Therapeutics (I); Roche (I)
Stock and Other Ownership Interests - Io Therapeutics; Juno Therapeutics (I); Roche (I)
Consulting or Advisory Role - Sophiris Bio
Patents, Royalties, Other Intellectual Property - Io Therapeutics
Other Relationship - Acousys Biodevice; Laurel therapeutics; seurat therapeutics
 
Rosh Chandraratna
Employment - Io Therapeutics
Leadership - Io Therapeutics
Stock and Other Ownership Interests - Allergan; Io Therapeutics
Research Funding - Io Therapeutics
Patents, Royalties, Other Intellectual Property - Io Therapeutics
 
Ethan Dmitrovsky
No Relationships to Disclose
 
Konstantin H. Dragnev
Consulting or Advisory Role - Boehringer Ingelheim